Posts Tagged ‘pancreatic cancer’

Treating Pancreatic Cancer

pancreatic cancer imagePancreatic cancer is a very aggressive disease that is prone to metastasizing or spreading. Unfortunately, it has been rising in incidence in the United States with approximately 50,000 new cases per year. Treatment for pancreatic cancer varies depending on the individual patient, but when determining surgical treatment options we consider these questions: Has the tumor spread? Is it removable? And is the patient in good enough shape to have surgery?

If surgery is an option, the approach for pancreatic cancer is dictated by where the tumor is located, and the surgeon may remove parts or, in rare circumstances, the entire pancreas. Most tumors are diagnosed in the head of the pancreas, and these can be removed with a pancreaticoduodenectomy, also known as the Whipple procedure. The Whipple procedure, an aggressive operation that typically takes between three to six hours to complete, involves removing a third of the pancreas and part of the intestines called the duodenum. However, if the tumor is on the other side of the pancreas then it can be removed with something called a distal pancreatectomy, which involves less reconstruction than the Whipple procedure.

In addition to the standard surgical options, we also utilize technologically advanced, minimally invasive surgical approaches using laparoscopy and robotic surgery. Laparoscopic surgery involves placing medical instruments in the belly through tubes, which results in smaller incisions. This approach can get patients out of the hospital a little faster because of less blood loss and fewer complications than standard surgery. We are also using cutting-edge robotic surgery for pancreatic cancer. This technology can be used in the Whipple procedure and the distal pancreatectomy, and the robot provides the surgeon with incredible dexterity. While traditional laparoscopic instruments do rotate and open and close, the robot has wrists and 3D visualization. This allows the surgeon to see things with good depth perception instead of looking at a flat screen, which can be especially helpful for complex surgeries in confined areas. The surgical robot is a valuable, minimally invasive tool for selective circumstances, although it is not necessary for all pancreatic procedures.

About Dr. Kooby

koobyDavid A. Kooby, MD, FACS, is a board certified surgical oncologist specializing in laparoscopic and open surgical treatment of pancreas, bile ducts, stomach, and colon cancers. Dr. Kooby is a pioneer in minimally invasive and robotic pancreatic surgery, and serves as Professor of Surgical Oncology in the Department of Surgery at Emory University School of Medicine. Dr. Kooby also is the Director of Surgical Oncology at Winship at Emory Saint Joseph’s Hospital and the Director of Minimally Invasive GI Surgical Oncology at Emory University School of Medicine. Dr. Kooby will be co-directing the International Hepato-Pancreato-Biliary Association State of the Art Conference


Pancreatic cancer at Winship
Steve Jobs, pancreatic cancer & the Whipple Procedure 
Intro to Pancreatic Cancer Part I: Stats, Types, & Risk Factors
An Intro to Pancreatic Cancer Part II: Prevention, Diagnosis & Treatment
5 Early-Distress Warnings of Digestive Cancer

Pancreatic Cancer Surgery Options

There are a variety of treatment options for pancreatic cancer depending on the size and location of the tumor, whether the cancer has spread and the overall health of the patient.   Dr. David Kooby, surgical oncologist at Winship Cancer Institute of Emory University, describes the surgical treatment options available to patients diagnosed with pancreatic cancer.

Procedures include:

Whipple Procedure or Pancreaticoduodenectomy: this method is used when the tumor is in the head of the pancreas. The surgeon removes the head of the pancreas and parts of the bile ducts, small intestines and stomach.

Distal Pancreatectomy: in this procedure, the body and tail of the pancreas are removed in addition to the spleen.

Total Pancreatectomy: the entire pancreas is removed along with part of the small intestine, a portion of the stomach, the common bile duct, the gallbladder, the spleen, and nearby lymph nodes.

Learn more about Winship Cancer Institute of Emory University

Pancreatic Cancer: Incidence and Outlook

Pancreatic cancer increases with age and most people are between 60 to 80 years old when diagnosed. Early pancreatic cancer often does not cause symptoms. Pancreatic cancer can affect anyone. People with a family history of pancreatic cancer in first degree relatives have an increased risk.

Pancreatic cancer specialist, Dr. David Kooby from Winship Cancer Institute of Emory University talks about why the disease is so prevalent and why it is so difficult to treat.

Learn more about Winship Cancer Institute of Emory University.

Risk Factors and Symptoms of Pancreatic Cancer

The pancreas is a flat, banana-shaped organ that is located behind the stomach. Functionally, it can be regarded as two separate organs based on the chemicals each produces. The exocrine pancreas makes up the largest part of the gland and is responsible for creating enzymes that help break down foods we eat so that they can be used by the body. The endocrine pancreas is composed of groupings of cells that make up a much smaller part of the gland. These cell clusters, called islets, are responsible for producing hormones, such as insulin, that help regulate the amount of sugar in the blood.

What are the risk factors and symptoms of pancreatic cancer? Winship surgical oncologist, Dr. David Kooby answers those questions.

Learn more about Winship Cancer Institute of Emory University.

Takeaways from the Pancreatic Cancer Live Chat at Winship

Pancreatic Cancer Chat

Thanks to everyone who joined us Tuesday, May 12th for the live online pancreatic cancer program chat at Winship Cancer Institute of Emory University hosted by Drs. El-Rayes & Kooby.

Drs. El-Rayes & Kooby answered several of your questions about pancreatic cancer risk factors, symptoms and therapy. There are a variety of treatment options for pancreatic cancer; for some patients, a combination of treatment methods may be used. Check out the conversation by viewing the chat transcript! Here are just a few highlights from the chat:

Question: Who is at the most risk for pancreatic cancer?

David Kooby, MDDr. Kooby: Pancreatic cancer can affect anyone. People with a family history of pancreatic cancer in first degree relatives have an increased risk. Smokers are at risk, as tobacco appears to be a causative factor. Other groups who have an elevated risk of getting pancreatic cancer are those with new onset or long-standing diabetes mellitus and those with one of several uncommon genetic syndromes: BRAC2, HPSS, FMS, Peutz Jegher. Other associations include age over 60, chronic pancreatitis, and obesity. Many of the symptoms for pancreatic cancer are vague, which makes this a difficult disease to diagnose.

Question: When surgery is not an option, are there any treatments beyond chemo and radiation?

Bassel El-Rayes, MDDr. El-Rayes: A number of novel therapies are currently on clinical trials and those include drugs that stimulate the immune system or drugs that target specific molecular abnormalities in cancer (targeted therapies). In addition, in certain situations there are options to use therapies that ablate (physically destroy the tumor). These include nano knife.


Question: Are qualifying patients given the option to participate in these trials Dr. El-Rayes?

Bassel El-Rayes, MDDr. El-Rayes: When we evaluate patients in the clinic, we always discuss with them the different options of therapy, including, standard therapy vs. clinical trials. For patients to participate in clinical trials, they have to meet predefined criteria. If patients are interested in clinical trials, we will screen them to determine whether or not the meet these criteria.


Question: My sister and brother have both been diagnosed with pancreatic cancer within months of each other. There are three remaining siblings. Can you address how we can be tested?

Bassel El-Rayes, MDDr. El-Rayes: The first step would be to see a genetic counselor to look for a possible genetic link. There, they can test for specific genes that might indicate a higher risk in the family.
David Kooby, MDDr. Kooby: If the genetic testing doesn’t yield any abnormality, the second step would be to consult with a pancreatic cancer specialist. These specialists are either gastroenterologists or medical oncologists. Currently, there are no set guidelines on how frequently family members of current patients should be tested. Your specialist can outline a plan that works best for you and your family. Researchers at institutions like Winship are actively working on better methods for screening for pancreatic cancer.

If you missed this chat, be sure to check out the full list of questions and answers on the web transcript. For more information go to the Pancreatic Cancer at Winship Cancer Institute website or 404-778-7777 to learn more from a registered nurse.

If you have additional questions for Drs. El-Rayes & Kooby, feel free to leave a comment in our comments area below.

Related Resources




5 Early-Distress Warnings of Digestive Cancer

pancreatic cancer live chatWhen you think of digestion you probably don’t think about the pancreas, but it sits right behind the stomach and works to provide essential digestive functions. The pancreas, only about 4- 6 inches long, is widely known for producing insulin, an important hormone that regulates blood sugar levels, but it also assists the body in the absorption of nutrients into the small intestine.

Pancreatic cancer increases with age and most people are between 60 to 80 years old when diagnosed. Early pancreatic cancer often does not cause symptoms, however there are five early warning signs that we can all be aware of to better advocate for our health.

  1. Yellow eyes or skin.  The pancreas uses a greenish-brown fluid made in the gallbladder, called bile, to help the small intestine in digestion. If a tumor starts in the head of the pancreas, it can block or press on the bile duct and cause bile to build up. This back-up causes yellow discoloration, called jaundice.
  2. Belly pain.  Pain has been described as distressing, as compared to a sharp cramp or ache. Pain may go away when you lean forward because it and spreads toward the back.
  3. Change in stool.  Pale, floating, smelly stools. Or dark stools. Let your stool be a guide. If a pancreatic tumor prevents digestive fluids from reaching the intestine, the result is an inability to digest fatty foods. Anytime there is a change with digestion then check in with your doctor. It may not be a sign of digestive cancer, but you do need to be aware of your own body function to determine what is or is not “normal.”
  4. Lack of appetite.  Or sudden, unexplained weight loss. A drop in appetite and a tendency to feel full after eating very little is something to be aware of. Again, it may not be alarming but you do need to be aware of your own body function to determine what is or is not “normal.”
  5. Diabetes, especially if unexpected from regular check-ups.  Most diabetes diagnoses are not due to pancreatic cancer; however, research studies show that pancreatic cancer patients have a higher rate of diabetes diagnosis than the general populace. Knowing your family history of pancreatic cancer and having a baseline of regular screening will help your doctor evaluate if additional tests should be done.

Being an advocate for your health starts with healthy behaviors; tobacco use, particularly cigarette smoking, accounts for 20-30% of pancreatic cancer. Knowing risk factors you should avoid (such as smoking) and being aware of what your body is signaling will help you in early detection as well as potential outcome.

Management of cancer requires a multidisciplinary team of healthcare specialists. Winship’s pancreas cancer team includes surgeons, medical oncologists, radiation oncologists, gastroenterologists, pathologists as well as pain specialists, nutritionists and social workers. For patients with early stage pancreatic cancer, the Whipple surgical procedure is the best option for long-term survival. Winship Cancer Institute of Emory University surgeons perform a large number of Whipple procedures every year; a high volume of these procedures directly translates into the expertise needed to perform the procedure safely. According to published data, mortality rates from Whipple surgery are four times lower at hospitals performing a high volume of the procedure, such as Emory. Some patients may be candidates for laparoscopic or robotic surgery, which may improve both recovery and cosmetic appearance after surgery. Winship at Emory surgeons are leading the world in this area as well. If diagnosed with cancer it’s important to get to Winship, first.

Continue learning about pancreatic with a conversation; all are welcome to attend an online open-forum discussion about pancreatic cancer. We will answer your questions about pancreatic cancer risk factors, symptoms and therapy on Tuesday, May 12th, 2015 at noon.

Chat Sign Up

About Dr. El-Rayes

Dr. El-Rayes, Colon Cancer SpecialistBassel El-Raye, MD, is the Director of the GI Oncology Clinical and Translational Research Program, Associate Cancer Research Director for Clinical Research at Winship Cancer Institute of Emory University and Professor of Hematology and Oncology at Emory University School of Medicine. Dr. El-Rayes earned his bachelor’s degree in biology and doctoral degree from the American University of Beirut. He then completed his residency in internal medicine and fellowship in hematology and medical oncology at Wayne State University, Detroit. He was on faculty at Wayne State University Karmanos Cancer Institute from 2003-2009. Dr. El-Rayes clinical interests include gastrointestinal malignancies specifically pancreatobiliary and neuroendocrine cancers. He is principle investigator on multiple investigator initiated trials. He has served on the gastrointestinal committee for Southwest Oncology Group (SWOG) and Radiation Oncology Cooperative Group (RTOG). He currently serves on the National Cancer Institute Neuroendocrine Tumor (NET) Task Force. He also serves as Co-chair of Hoosier Oncology Group (HOG) Cancer Research Network – Gastrointestinal Clinical Trials Working Group. Dr. El-Rayes is a Georgia Cancer Coalition Distinguished Clinical Scholar. He has published over 90 peer reviewed articles in elite journals including Journal of Clinical Oncology and Cancer Research.

About Dr. Kooby

David Kooby, MDDavid A. Kooby, MD, FACS, specializes in laparoscopic/robotic and open surgical treatment of liver, bile duct, pancreas, stomach, and colon tumors/cancers. He also has expertise with tumors and diseases of the spleen, adrenal glands, and retroperitoneum. He has taught many national courses on laparoscopic resection of the liver, pancreas, and colon, and is frequently invited to speak at national conferences. He received his MD at the State University of New York, Downstate Medical College, Brooklyn, NY, in 1994; completed his surgical residency at Vanderbilt University, where he won medical student and resident teaching awards. He completed both bench research and clinical fellowships at Memorial Sloan-Kettering Cancer Center, New York, NY. He was recruited by Emory in 2003, and is currently an Associate Professor of Surgery in the Division of Surgical Oncology, Director of Surgical Oncology at Emory/Saint Joseph’s Hospital, and Director of Minimally Invasive GI Surgical Oncology. He serves on several national committees including the task force charged with updating the staging of hepatobiliary malignancies for the American Joint Committee on Cancer’s Cancer Staging Manual, the research and education committee for the American Hepato-Pancreato-Biliary Association, and the Hepatobiliary Working Group for the Society of Surgical Oncology. He is leader in multicenter clinical research and is a national leader in minimally invasive pancreatic surgery.

Related Resources

Bite into a Healthy Lifestyle
An Intro to Pancreatic Cancer Part I: Stats, Types, & Risk Factors
Steve Jobs, Pancreatic Cancer & the Whipple Procedure

Simple Gifts

Emory Healthcare Market Services Team

Chatting before the start of an editorial meeting, Lynne Anderson told us about a family she had adopted through Winship’s Adopt-A-Family program, one supporting needy families stricken by cancer.  My colleague Morgan and I were so moved and unexpectedly brought to tears by the story (I didn’t even have tissues ready!) that we proposed our marketing team adopt a family as our group’s annual holiday community building event.  Everyone readily agreed – and even better to be helping members of our own Emory community.

While participation was voluntary, it wasn’t surprising that we had 100% participation from our team. After all is there a more noble cause then helping a family in need when confronted by a life-threatening illness? Even though we weren’t able to fill every wish on our family’s list, we were able to provide enough so that every member of the 6-person family, whose patriarch is battling pancreatic cancer, would each have a few gifts under the tree and also provide a gift card to help with daily expenses. In addition to helping a family, it gave our team a chance for fellowship as we gathered to wrap gifts and enjoy a few moments away from the hectic pace of the busy work day.

Our whole team got to benefit from the joy of giving, but I was honored to be the one to deliver the gifts to the family.  The mom and granddaughter greeted me at the door when I arrived. The rest of the family simply enjoying each other’s company sitting by the tree, catching up on the daily news or finishing the day’s homework. They were gracious accepting our humble gifts.  The youngest among them already delighted to play with the colorful bows.  I didn’t stay very long, but I was there long enough to feel the love in the room and their appreciation for a group of strangers who wanted to bring a little joy to their family for Christmas.

As I was driving home down winding country roads and gazing out over the serene rolling hills, Aaron Copeland’s Simple Gifts movement from his ballet Appalachian Spring popped into my head.  Da dum, da da dum dum, da da dum, da da dum…. I have been humming, singing the simple beautiful tune ever since, thinking about this family.  I hope, dare I say I know, we brought them some extra joy and blessings for the holidays.  But I just can’t stop thinking, what happens to this family on December 26th or February, March, April? Long after the decorations are put away and we go about our daily lives with the giving spirit of the season left behind us for another year, what happens to this and other families still in need?

Unfortunately long-term survival rates for pancreatic cancer patients are bleak with the 5-year survival rate barely reaching 6%1.  While I desperately hope otherwise, I know even tougher times are ahead this family as the dad’s cancer progresses.  When he can no longer work, who will be there to help?  And how will they pick up the pieces and move on when the inevitable happens?

While little can help ease the emotional struggle, at least there are options to help with financial hardship.  I was pleased to learn that Winship has a patient assistance fund to help families-in-need year-round.  So as you are considering your new year’s resolutions for 2012, instead of making empty promises to yourself, why not consider how you can help extend the holiday spirit throughout the year?  Whether it is donating funds to a program like Winship’s Patient Assistance Fund or by volunteering at a soup kitchen in the spring, there are many simple ways to help families in need throughout the year.

Our simple gifts mean much to these families. So now instead of feeling down as I hum my the shaker tune, I am hopeful and reminded of the joy givers and receivers find in simple gifts.

Simple Gifts (By Elder Joseph Brackett Jr., 1848)

‘Tis the gift to be simple, ’tis the gift to be free, ‘Tis the gift to come down where we ought to be, And when we find ourselves in the place just right,’Twill be in the valley of love and delight.When true simplicity is gain’d, To bow and to bend we shan’t be asham’d, To turn, turn will be our delight ‘Till by turning, turning we come round right.

How Can I Help?

If you’re interested in helping a family of a cancer patient not just during the holidays, but year-round, the Winship Cancer Institute of Emory University’s Patient Assistance Fund helps provide assistance to families throughout the year. Please use the link above for more information, or contact Mark Hughes by phone at: 404-778-1288 or via email at:

Related Resources:

An Intro to Pancreatic Cancer Part II: Prevention, Diagnosis & Treatment

Pancreatic Cancer Awareness Month


November is Pancreatic Cancer Awareness Month. Last week, we gave you an intro to Pancreatic Cancer, including statistics, information on the types of pancreatic cancer, and pancreatic cancer risk factors. As promised, this week, we’re following up with information on preventing, diagnosing and treating cancer of the pancreas.

Pancreatic Cancer Prevention

Much of the advice you’ll see for cancer prevention is similar across cancers. A few things you can do to help improve your health and fight off cancer, including pancreatic cancer, include: quitting smoking, exercising regularly, eating a healthy, well-balanced diet, and maintaining a healthy weight.

Diagnosing Cancer of the Pancreas

Diagnosing cancer of the pancreas can involve a variety of tests and assessments. As is true in any attempt to diagnose a medical condition, a thorough evaluation of a patient’s medical history, risk factors, and symptoms is conducted. Imaging tests, including CT, MRI, PET, ultrasound, and others may be used along with potential biopsies and blood tests.

Treating Cancer of the Pancreas

There are three main modes of treatment in combating pancreatic cancer:

  1. Surgery – Parts or the entire pancreas may be removed depending on the location and stage of the pancreatic cancer. The whipple procedure can be used when the cancer is in the head of the pancreas and involves the removal of the head of the pancreas and parts of the bile ducts, small intestine, and stomach; distal pancreatectomy removes the body and tail of the pancreas and the spleen; and total pancreatectomy removes the entire pancreas, part of the small intestine, a portion of the stomach, the common bile duct, the gallbladder, the spleen, and nearby lymph nodes.
  2. Chemotherapy – Chemotherapy is medication delivered to the body to eliminate cancer cells or greatly reduce their effect. It targets cells that divide rapidly, a characteristic of most cancer cells. Chemotherapy is often used to support and enhance other cancer treatment modalities.
  3. Radiation Therapy – Radiation therapy is a type of cancer treatment that uses ionizing radiation energy to kill cancer cells and shrink cancerous tumors. Radiation therapy serves to either destroy cancerous cells or damage these cells to impede the division and growth of the cancer.

Physicians at the Winship Cancer Institute of Emory University specialize in these treatments, while researchers at Winship are exploring new and novel treatments for pancreatic cancer, including a number of clinical trials for pancreatic cancer treatment.

Related Resources:

Intro to Pancreatic Cancer Part I: Stats, Types, & Risk Factors

Pancreatic Cancer Awareness Month

November is Pancreatic Cancer Awareness Month. Before we dig a bit deeper into pancreatic cancer in this two-part blog post, below are some important stats you should be aware of. According to the National Cancer Institute (NCI) and American Cancer Society:

  • pancreatic cancer is the 4th leading cause of cancer-related death in both men and women in the U.S.
  • 1.41% of men and women born today will be diagnosed with cancer of the pancreas at some time during their lifetime
  • the median age for diagnosis of pancreatic cancer was 72 years old (based on data from ‘04-’08)
  • the median age of death as a result of pancreatic cancer was 73 years old (based on data from ‘04-’08)
  • 0.53% of men will develop cancer of the pancreas between their 50th and 70th birthdays compared to 0.39% for women
  • About 44,030 people (22,050 men and 21,980 women) will be diagnosed with pancreatic cancer.

Pancreatic Cancer Types

According to the Winship Cancer Institute of Emory University, “A pancreatic cancer type is based on the location of the tumor’s origin within the pancreas. More than 95 percent of pancreatic cancers are adenocarcinomas of the exocrine pancreas. Tumors of the endocrine pancreas are much less common and most are benign.”

  • Acinar Cell Cancers: Acinar cell cancers are tumors that form on the ends of the pancreatic ducts.
  • Adenocarcinoma: An adenocarcinoma is a cancer that begins in the cells that line certain internal organs and have secretory properties. In the pancreas, this is a cancer of the exocrine cells that line the pancreatic ducts.
  • Cystic Tumors: Cystic tumors derive their name from the presence of fluid filled sacs within the pancreas. The fluid is produced by the lining of abnormal tissues or tumors. These tumors may lead to cancer in some patients; however, most cystic tumors of the pancreas are benign.
  • Sarcomas: Sarcomas are tumors that form in the connective tissue that bonds pancreatic cells together and are rare.

Pancreatic Cancer Risk Factors

  • Age:  Nearly 90% of those with pancreatic cancer are older than 55 years and over 70% are older than 65.
  • Gender: Pancreatic cancer incidence rates are higher among men than women, but it is possible that this can be attributed to higher tobacco use incidence rates among men.
  • Weight: According to the NCI, “In a pooled analysis of clinical data,  higher body mass index was associated with an increased risk of developing pancreatic cancer, independent of other risk factors.”
  • Cigarette Smoking: According to the American Cancer Society, pancreatic cancer risk is 2-3x higher for smokers than non-smokers. About 20% to 30% of exocrine pancreatic cancer cases are thought to be caused by cigarette smoking.

Next week, we’ll follow up with more information on pancreatic cancer, including steps you can take to lower your risk (prevention), symptoms of cancer of the pancreas, and how pancreatic cancer is diagnosed and treated.

In the meantime, if you have questions about pancreatic cancer, please leave them for us in the comments below. All comment responses will be provided by physicians of Emory Healthcare and/or the Winship Cancer Institute of Emory University.

Steve Jobs, Pancreatic Cancer & the Whipple Procedure

Dr. David Kooby, Emory10/6/2011 Update – A true visionary and leader in his field, we honor Steve Jobs (1955-2011) for his contributions and celebrate the tremendous impact he has had on the world. A reminder that we have a long way to go in the field of pancreatic cancer treatment. He will be deeply missed.

Most of you have probably heard the news that Steve Jobs has stepped down as Apple’s CEO. As he puts it, “I’ve always said if there ever came a day when I could no longer meet my duties and expectations as Apple’s CEO, I would be the first to let you know. Unfortunately, that day has come.” Jobs’ resignation comes not as a surprise to most. He was diagnosed with a rare type of pancreatic cancer in 2003 after doctors found his islet cell neuroendocrine tumor, a pancreatic cancer type that affects only about 2,000 of the 43,000 (~5%) people diagnosed with pancreatic cancer each year.

After receiving his pancreatic neuroendocrine cancer diagnosis, Jobs underwent surgery known as a pancreaticoduodenectomy (Whipple procedure) in 2004 to remove his cancer. The Whipple procedure involves removing a portion (the head) of the pancreas along with several surrounding organs, with the intent of rendering the patient cancer free. While it is a complex operation with substantial risk of complications and even death, for some patients with cancers of the pancreas like Jobs, it may provide the only hope for a cure.

The outcomes of the Whipple procedure are largely dependent on the unique circumstances of the patient, the tumor, and the expertise of the surgical team performing the procedure. What is known, however, is that survival rates from the Whipple procedure are higher at hospitals that specialize in this type of surgery. A recent study of the Whipple procedure reported in The New England Journal of Medicine found that operative mortality rates to be four times higher at low-volume hospitals (16%) than at high-volume hospitals (3.8%). Emory Healthcare is home to one of few of the Southeast’s high volume Whipple procedure programs, having performed 119 Whipple procedures in 2010 alone.

We know the risks and we know what it takes to reduce them. Emory has created a clinical pathway for Whipple procedure patients, making sure every step is taken to support quality outcomes and increase the hope for survival from cancer of the pancreas. A minimally invasive approach may be an option for selected patients who are in need of this operation.

Related Resources:

Pancreatic cancer Whipple procedure Sanjay GuptaYou can hear more about Steve Jobs, his pancreatic cancer diagnosis and treatment options in this CNN video interview with Dr. Sanjay Gupta and Dr. David Kooby of Emory.



Learn more about how Emory is improving outcomes for patients needing the Whipple procedure and more about the program, or check out the video below:

Learn more about pancreatic cancer and how it’s treated at the Winship Cancer Institute of Emory University.